| Literature DB >> 28012446 |
Takuma Kato1, Mikio Sugimoto1, Motoki Yamashita1, Yasuyuki Miyauchi1, Hiromi Hirama1, Hiroyuki Tsunemori1, Nobufumi Ueda1, Hitomi Imachi2, Shinsuke Shibuya3, Yoshio Kushida3, Yoshiyuki Kakehi1.
Abstract
Insulin-like growth factor 2 is overexpressed in various cancers, and is associated with a poor prognosis. Also, it is known that insulin-like growth factor 2 is an etiology of non-islet cell tumor hypoglycemia. In this report, we describe a case of unexpected hypoglycemia caused by a dedifferentiated liposarcoma producing insulin-like growth factor 2. A large mass in the retroperitoneum was detected in a 61-year-old man who complained of appetite loss. Despite having no history of diabetes mellitus, hypoglycemia suddenly occurred after admission, but oral glucose therapy was ineffective. After total parenteral nutrition, tumor resection was attempted, but failed as a result of rigid adhesion to the surrounding organs. The patient died of the disease 21 days after surgery. Pathological diagnosis at autopsy revealed dedifferentiated liposarcoma, and immunohistochemical staining showed that the tumor excreted insulin-like growth factor 2. The possibility of an insulin-like growth factor 2-producing tumor should be taken into consideration when we encounter a patient with spontaneous hypoglycemia resistant to glucose substitution therapy.Entities:
Keywords: dedifferentiated liposarcoma; hypoglycemia; insulin-like growth factor 2; non-islet cell tumor hypoglycemia
Mesh:
Substances:
Year: 2016 PMID: 28012446 DOI: 10.1111/iju.13276
Source DB: PubMed Journal: Int J Urol ISSN: 0919-8172 Impact factor: 3.369